DONALD A. WILLIAMS - 01 Jan 2024 Form 3 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Rachelle Jacques, as Attorney-in-Fact for Donald Williams
Issuer symbol
AKTX
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
3
Filing time
02 Jan 2024, 18:35:30 UTC
Next filing
02 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AKTX Ordinary Shares, par value $0.0001 per share 20,000,000 01 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.1454 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.1454 Direct F1
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.0504 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.0208 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 750,000 $0.0175 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.0207 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.0218 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.0173 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 1,300,000 $0.0100 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 3,700,000 $0.004800 Direct
holding AKTX Stock Option (Right to Buy) 01 Jan 2024 Ordinary Shares, par value $0.0001 per share 5,000,000 $0.001700 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Non-qualified stock option granted under the Issuer's 2014 Equity Incentive Plan. The stock option vested and became exercisable ratably in three equal installments with the first installment vesting on the date of the Issuer's first Annual General Meeting ("AGM") following the date of the grant, and with the second and third installments vesting, respectively, on the dates of the Issuer's second and third AGM's following the date of the grant.
F2 Non-qualified stock option granted under the Issuer's 2023 Equity Incentive Plan. One-hundred percent (100%) of the stock option vests and becomes exercisable on the date of the Issuer's 2024 Annual General Meeting.

Remarks:

See Exhibit 24.1 - Power of Attorney